|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,166,425 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
17,044 |
Total Sell Value |
$0 |
$0 |
$0 |
$5,919,264 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
10 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Thomas Paul |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
12,703 |
|
- |
|
Sutter Martin P |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
231,849 |
|
- |
|
Puhy Dorothy E |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
22,364 |
|
- |
|
Rose Eric A Md |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
13,183 |
|
- |
|
Rivet Jeannine M |
Director |
|
2018-08-08 |
4 |
A |
$0.00 |
$0 |
D/D |
531 |
6,946 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-07-30 |
4 |
AS |
$352.15 |
$6,879,302 |
D/D |
(19,282) |
147,842 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-07-30 |
4 |
OE |
$22.44 |
$246,840 |
D/D |
11,000 |
167,124 |
|
- |
|
Sutter Martin P |
Director |
|
2018-06-30 |
4 |
A |
$409.05 |
$16,771 |
D/D |
41 |
231,318 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-06-21 |
4 |
AS |
$434.47 |
$46,166,971 |
D/D |
(105,000) |
376,150 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-06-21 |
4 |
OE |
$10.03 |
$1,053,150 |
D/D |
105,000 |
481,150 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-06-18 |
4 |
AS |
$437.07 |
$20,582,164 |
D/D |
(46,500) |
156,124 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-06-18 |
4 |
OE |
$10.03 |
$336,005 |
D/D |
33,500 |
202,624 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-06-15 |
4 |
D |
$440.65 |
$9,047,866 |
D/D |
(20,533) |
169,124 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
92,280 |
189,657 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-06-15 |
4 |
D |
$440.65 |
$22,619,446 |
D/D |
(51,332) |
376,150 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2018-06-15 |
4 |
A |
$0.00 |
$0 |
D/D |
230,700 |
427,482 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2018-05-24 |
4 |
D |
$395.52 |
$759,003 |
D/D |
(1,919) |
97,377 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2018-05-24 |
4 |
D |
$395.52 |
$586,952 |
D/D |
(1,484) |
48,394 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2018-05-24 |
4 |
D |
$395.52 |
$586,952 |
D/D |
(1,484) |
62,126 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2018-05-24 |
4 |
D |
$395.52 |
$586,952 |
D/D |
(1,484) |
50,492 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2018-05-24 |
4 |
D |
$395.52 |
$2,844,580 |
D/D |
(7,192) |
197,962 |
|
- |
|
Sutter Martin P |
Director |
|
2018-05-23 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,200 |
186,833 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2018-05-18 |
4 |
GA |
$0.00 |
$0 |
I/I |
75,485 |
38,560 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2018-05-18 |
4 |
GD |
$0.00 |
$0 |
I/I |
74,305 |
46,654 |
|
- |
|
Minogue Michael R |
President, CEO, Chairman |
|
2018-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,180 |
196,782 |
|
- |
|
740 Records found
|
|
Page 13 of 30 |
|
|